研究单位：[1]AstraZeneca[2]Douglas Hospital and Research Centre Verdun,Quebec,Canada,H4H 1R3[3]Xuanwu Hospital-Capital Medical University Beijing,Beijing,China,100053[4]Beijing 301 Hospital Beijing,Beijing,China,100853[5]Guangzhou First People's Hospital Guangzhou,Guangdong,China,510180[6]Tangshan Worker Hospital Tangshan,Hebei,China,063000[7]Nanjing Drum Tower Hosp Affiliated Hosp of Nanjing Univ Med Nanjing,Jiangsu,China,210008[8]Zhongda Hospital-Southeast University Nanjing,Jiangsu,China,210009[9]Northern Jiangsu People's Hospital Yangzhou,Jiangsu,China,225001
研究目的：
The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.
